Summary: Angiotensin-converting enzyme (EC 3.4.15.1) exhibhs distinctive tissue differences in electrophoretic behaviour. Human tissue homogenates and biological fluids were subjected to agar gel and polyacrylamide gel electrophoresis. The gels were cut into slices and enzymatic activity detected by a specific colorimetric reaction. The technique allows localization of the enzyme in the electrophoretogram and gives an estimate of the total enzymatic activity of a tissue or biological fluid. Several tissues were found to show multiple forms of angiotensin-converting enzyme. The specificity of the assay was determined by running the samples after the addition of captopril and by adding proteinase inhibitors to the incubation mixture.
purified enzyme has been reported in several cases. Fitz & Ovenwf(3) provided evidence for the existence of more than one angiotensin-converting enzyme. The elution pattern (Sephadex G-200) of an ammonium sulphate precipitated preparation of human lung showed two peaks of angiotensin-converting enzyme. The authors suggested that more than one enzyme could be involved in the conversion of angiotensin I, perhaps by causing sequential peptide loss from the COOH-terminal of the molecule.
A 500-fold purification of converting enzyme from human seminal plasma on Sephadex G-200 also yielded 2 fractions with different moJecular weights. Both were inhibited by the nonapeptide SQ 20,881 (4).
Oshima et al. (5) purified angiotensin-converting enzyme from hog kidney by a combination of several Chromatographie techniques (DEAE-cellulose, calcium php^phate gel, DEAE-Sephadex A-50, hydroxylapatite, Sephadex G-200) and found in the purified enzyme two protein bands on Standard disc electrophoresis. A single protein component was obtained in the gel after treatment with neuraminidase (EC 3.2.1.18). The two bands were both active enzymes, differing only in sialic acid content.
In homogenates of human placenta, Litrowicz & Maloßejew (6) found, after enzyme Filtration on Sephadex G-200, 3 protein peaks of converting enzyme. After purification of converting enzyme from human lung, Grönhagen-Riska & Fyhrquist (7) showed one major and one faint band. These authors suggested that the different enzymatic peaks in Sephadex elutions represent polymeric forms of the enzyme.
Using polyacrylamide gel electrophoresis, Hara et al. (8) found two peaks of converting enzyme in granulomatous lesions of the skin of patients with beryllium-induced hypersensitivity. Two peaks with the same mobility äs those from pathological sources were also found in normal dermis. The aim of the present study was to show the heterogeneity of converting enzyme in crude tissue homogenates, using the capacity to cleave histidyl-leucine from an artificäl Substrate, äs well äs Inhibition with captopril in low concentrations, äs criteria for the definition of the enzyme.
The multiple forms of angiotensin-converting enzyme lend support to the hypothesis of the existence of enzymes with quantitatively different sialic acid con-« tent in the homogenates and biological fluids studied.
Materials and Methods

Human material
Serum was obtained from blood-bank donors, sperm from healthy donors and prostatic fluid from vasectomized individuals. All fluids were frozen in liquid nitrogen and stored at -87 °C äs rapidly äs possible. The following tissues were obtained from surgical patients: prostate (from patients with prostate-carcinoma, or benign prostatic hypertrophy, or normal prostate tissue from patients with bladder cancer), kidney, testis, seminal vesicle, ductus deferens, bladder, stomach (antrum), ileum, appendix, colon transversum, gall bladder, rectum, spieen, vena saphena magna, skin, thyroid, signioid, liver, lung, skeletal inuscle, ovary and bone marrow. These were frozen äs soon äs possible in liquid nitrogen and stored at -87°C.
Reagents
Hippuricase (EC 3.5.1.14) and the enzyme Substrate, /?-hydroxybenzoyl-glycyl-L^histidyl-L-leucine were obtained from Fujirebio Inc., Tokyo, Japan. The agar employed (Agar Noble) was obtained from Difco, Detroit, Michigan, USA. Polyacrylamide reagents for disc electrophoresis were from Eastman-Kodak, Rochester, N.Y., USA. Captopril (SQ 14225) was a generous gift from Squibb, Belgium. Nonidet P40 was from L.K.B., Bromma, Sweden. Soybean trypsin Inhibitor from Worthington Biochemical Corporation, Freehold, N.J., USA. N-ethyl-maleimide from Aldrich, Milwauky, Wisconsin, pepstatin from Protein Research Foundation, Osako, Japan and aprotinin from Bayer, F.R.G. Octyl-ß-/}-glycppyranoside was from Calbiochem-Behring, La Jollä, California, USA. Human albumin was obtained from Sigma Chemicals, St. Louis, Missouri, USA, and Macrodex, a depolymerized dextran (M T 40000) was from Povite, Christiaens, Brüssels, Belgium. All othef reagents were of analytical grade (E. Merck, Darmstadt, F.R.G.).
Tissue hoinogenization
Tissue homogenates were prepared by grinding the tissue in an Ehejhem glass homogenizer with a teflon pestle, either by adding one drop of Nonidet P40 per 200 mg tissue, or according to the method of Lazo & Quinn : (9) , which utilizes a 30 mmol/i solution of octyl-ß-Z)-glycopyranoside.
Agar gel electrophoresis
After centrifugation at 50000 g for 30 min at 4 °C, the supernate of the homogenized tissue was used for electrophoresis. Agar gel electrophoresis was carried out äs described by Wieme (10) . Protein and enzyme electrophoresis was performed on microscope slides (2.5 7.6 cm) covered with l mm 10 g/l agar gel in a 0.04 mol/1 sodium barbital 0.09 mol/1 HC1 buffer (pH 8.4). Migration time was 25. min at 140 V. Along with the sample, 3 of a mixture of human albumin (10 mg) and Macrodex (0.2 ml) in l ml sodium barbital-HCl buffer was applied below the sample application site.
After electrophoresis the region between the migration points of albumin and Macrodex was cut into 10 slices. This distance was taken arbitrarily äs one unit (1.00), and the relative mobility (m r ) of the detected enzymes assigned accordingly.
Polyacrylamide gel electrophoresis
Disc electrophoresis of tissue homogenates was carried out by the procedure of Maurer (11) .
Glass tubes (0.6 85 mm) were utilized and the gel consisted of 75 g/l acrylamide, 2 g/l bis-acrylamide in a 0.08 mol/l tris(hydoxymethyl)-aminomethane 0.16 mol/1 HC1 buffer (pH 7.5). The electrode buffer solution, (pH 7.0) consisted of 0.3 mol/1 diethylbarbituric acid^O.Ol 1^91/1 Tris. Bromophenol blue was used s a tracker dye. Electrophoresis was performed at constant current (2.5 mA) per tube. After electrophoresis the gel was cut into 15 equal parts, between the migration point of albumin and the top of the gel.
Enzyme detection
Each slice of gel was incubated 16 h at 37 °C in a tube containing 0.5 ml incubation mixture, consisting of 10 mmol/1 Substrate, (p-hydroxybenzoyl-Gly-L-His-L-Leu), 3 kU/1 hippuricase and 2.5 mmol/1 4-amino-antipyrine in a 0.12 mol/1 borate buffer (pH 8.3) containing 0.7 mol/1 sodium Chloride.
After the incubation, 1.5 ml of a Stopper and developer solution containing NaIO 4 6.5 mmol/1, 3 mmol/1 ethylenediaminetetraacetic acid and 2 g/l Triton X-100 was added to each tube. The colour intensity produced by the quinoneimine dye was measured at 505 nm with a Beckman model 25 spectrophotometer.
Detection of catalytic activity was carried out s follows: The specificity of the reaction sequence for angiotensin-converting enzyme was tested by adding 0.1 ml l μιηοΐ/ΐ captopril to each incubation tube. Controls run with no enzyme and Substrate did not give any colour. For each biological fluid or tissue, at least two specimens from different patients were examin ed.
Results
Since the same sample volume (7 μΐ) wa$ employed for each determination, the electrophoretic procedure provides a relative estimation of the conVerting enzyme catalytic activity in the various tissues and fluids examined. The enzyme appears widespread, but the aniount of catalytic activity differs widely, depending on the type of tissue examined.
The results obtained by gar gel electrophoresis are represented in figure l, (a to j). For the sake pf clarity, the results are shown in groups of low and high enzyme activity.
Tissue homogenates with very high enzymatic activity are diluted before electrophoresis with physiological saline.
Benign prostatic hyperplasia has the highest angiotensin-converting enzyme activity of all the samples studied. Its major converting enzyme activity migrates in agar gel with a m r = 0.75. This is also the m r of the enzyme from prostatic fluid and of one of the two peaks of seminal plasma. The latter also has a very active component with m r = 0.45, coinciding with the m r of the converting enzyme of seminal vesicles. Further differences are exhibited by the enzyme from other tissues of the urogenital tract: converting enzyme from kidney and bladder migrates at m r = 0.55.
The enzyme from the tissues of the digestive tract, e. g. sigmoid and stomach, also migrates differently from those described above. The lower angiotensinconverting enzyme activity in normal prostate and prostate cancer than in benign prostatic hyperplasia is remarkable, but the enzyme activities have the same m r . In some tissues, an additional converting enzyme activity was found, which moved slowly (m r = 0.15) and showed a relatively small amount of enzymatic activity.
Compared with agar gel, polyacrylamide gel electrophoresis has a high resolving power for proteins, particularily when a stacking gel is used. However, the use of a stacking gel did not improve the enzyme Separation. THe polyacrylamide gel results obtained from some tissues are represented graphically in figure 2 . The patterns obtained are quite similar to those obtained by agar gel electrophoresis. However, one major difference is the enzymatic activity which remains either in the stacking gel, or in the sucrose solution in which the sample is added to the separating gel. The nature of this phenomenon is not clear, but presumably this could be due to enzyme aggregation. Addition of 0.1 ml l μπιοΐ/ΐ captopril to each incubation mixture completely inhibits the angiotensin-converting enzyme activity found in the majority of tissues. Residual activity was detected only in the stomach and the ileum tissue (fractions of 0.10 and 0.22 respectively).
The m r of fractions from the same tissue are always identical.-For example ( fig. 1) , the major converting enzyme activity for benign prostatic hyperplasia (n = 5) was always detected at m r = 0.75. The same m r was also found for normal prostate (n = 2) and prostatic adenocarcinoma (n = 2).
The reprpducibility of agar gel electrophoresis made it possible to locate the enzyme activity bands without staining the gel. Slices containing the enzyme activity were cut out of the gel and resubmitted to electrophoresis in another agar gel plate. After the second electrophoresis, the gel was cut again into slices and assayed s described above.
The same electrophoretic pattern s the original was always obtained from an excised fraction, which proves that each fraction found is a single component. The long incubation time could be the origin of some artefactual results. In order to exclude the effects of other proteinases on the Substrate, we added several proteinase inhibitors to the incubation mixture (12 peptidylpeptidases and proteases. The cleavage of the histidyl-leucine dipeptide from an artificial Substrate (p-hydroxybenzoyl-glycyl-L-histidyl-L-leucine) has been accepted for the determination of converting enzyme activity since the pioneer studies of Cushman & Cheung (13) . As far äs we know, the second criterion used, namely the Inhibition of the enzymatic activity by captopril in low concentration, has only been described for angiotensin-converting enzyme (14) . In order to study the multiple forms <rf angiotensinconverting enzyme activity, other proteases were inhibited with various inhibitors, and the Inhibition of converting enzyme activity by captopril was exploited. Using similar conditions, we developed twp reliable techniques for determining the electrophoretic behaviour of angiotensin-converting enzyme. In several human tissues and fluids, the enzyme can be resolved into two or more fractions with distinct electrophoretic mobilities.
